Bubonic plague claims 32 lives in Madagascar (Update)

by Lovasoa Rabary

Bubonic plague, which wiped out a third of Europe's population in the Middle Ages, has reared its ugly head in the African island state of Madagascar where 32 people have died in a fresh outbreak of the so-called Black Death disease, according to health authorities.

Some 84 suspected cases of bubonic plague—60 of them suspected of being pneumonic or pulmonary plague, a more virulent strain of the disease—have been reported in five of the island's 112 districts in the past month.

Pneumonic plague is caused by the same bacteria that occur in bubonic plague but, while bubonic plague is usually transmitted by bites from rat-borne fleas and can be treated with antibiotics, pneumonic plague can be inhaled and transmitted between humans without involvement of animals or fleas and, if untreated, has a very high fatality rate, experts say. It can kill within 24 hours.

Last year, Madagascar reported 60 deaths from bubonic plague. Poor hygiene and declining living standards as a result of a protracted political crisis since a coup in 2009 are cited as the primary causes of the spread of the disease.

Related Stories

Boy dies of bubonic plague in Kyrgyzstan

date Aug 26, 2013

A teenage boy has died of bubonic plague in Kyrgyzstan, the country's health officials confirmed Monday, adding that an epidemic was not likely.

US approves new treatment for ancient plague

date Apr 27, 2012

Hardly anyone succumbs to the bubonic plague these days, but US health authorities on Friday approved a new treatment for it and other forms of the potentially deadly bacterial infection.

Recommended for you

Score IDs patients with upper extremity DVT at low risk

date 9 hours ago

(HealthDay)—For patients with upper-extremity deep vein thrombosis (DVT), six easily available factors can be used to create a score that identifies those at low risk of adverse events during the first ...

Combined drug treatment combats kidney disease

date 19 hours ago

A recent discovery by drug researchers whereby coupling specific cell membrane receptors has altered kidney cell function has triggered a re-think of how to treat chronic kidney disease (CKD) more effectively.

Active substance targeting dreaded hospital germs

date 19 hours ago

In the German Center for Infection Research (DZIF), scientists have conducted clinical studies on an active substance against the dreaded hospital pathogen Staphylococcus aureus: a highly effective protein from bacteriophages ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.